Monday, June 20, 2016

Pandemic Emergency Financing Facility (PEF)

The World Bank Group today  launched the Pandemic Emergency Financing Facility (PEF), on May 21, 2016 in Japan as an innovative, fast-disbursing global financing mechanism designed to protect the world against deadly pandemics, which will create the first-ever insurance market for pandemic risk. 
  • Japan, which holds the G7 Presidency, committed the first $50 million in funding toward the new initiative.

The announcement came a week ahead of the May 26-27 Summit of Group of Seven Leaders in Ise-Shima, Japan. 
G7 leaders had urged the World Bank Group to develop the initiative during their May 2015 summit in Schloss-Elmau, Germany.
The new facility will accelerate both global and national responses to future outbreaks with pandemic potential. 
  • It was built and designed in collaboration with the World Health Organization and the private sector, introducing a new level of rigor into both the financing and the response.

The PEF includes an insurance window, which combines funding from the reinsurance markets with the proceeds of World Bank-issued pandemic (catastrophe, or Cat) bonds, as well as a complementary cash window. 
This will be the first time World Bank Cat Bonds have been used to combat infectious diseases. In the event of an outbreak, the PEF will release funds quickly to countries and qualified international responding agencies.
The insurance window will provide coverage up to $500 million for an initial period of three years for outbreaks of infectious diseases most likely to cause major epidemics, including new Orthomyxoviruses (e.g. new influenza pandemic virus A, B and C),Coronaviridae (e.g. SARS, MERS), Filoviridae (e.g. Ebola, Marburg) and other zoonotic diseases (e.g. Crimean Congo, Rift Valley, Lassa fever).  
Parametric triggers designed with publicly available data will determine when the money would be released, based on the size, severity and spread of the outbreak.
The complementary cash window will provide more flexible funding to address a larger set of emerging pathogens, which may not yet meet the activation criteria for the insurance window.
  • All 77 countries eligible for financing from the International Development Association, the World Bank Group’s fund for the poorest countries, will be eligible to receive coverage from the PEF. 
  • The PEF is expected to be operational later this year.

Recent economic analysis suggests that the annual global cost of moderately severe to severe pandemics is roughly $570 billion, or 0.7 percent of global GDP. 
A very severe pandemic like the 1918 Spanish flu could cost as much as 5 percent of global GDP, or nearly $4 trillion.
During the past two years alone, pandemic threats have included the devastating Ebola crisis in West Africa—which crippled the economies of Guinea, Liberia and Sierra Leone, and cost them an estimated $2.8 billion in GDP losses ($600 million in Guinea, $300 million in Liberia and $1.9 billion in Sierra Leone); the MERS outbreak, which took a toll on the South Korean economy; and the Zika virus that is spreading in the Americas and putting thousands of unborn children at risk.
Four global expert panels that were convened over the past year in the wake of the Ebola crisis concluded that the world must urgently step up its capacity for a swift response to outbreaks before they become more deadly and costly pandemics. 
The PEF will do a number of important things to prevent another Ebola crisis:
  • It will insure the world’s poorest countries against the threat of a pandemic.
  • In the event of a severe infectious disease outbreak, it will release funds quickly to the countries and/or to international responders, to accelerate the response—saving lives and reducing human suffering. 
  • By mobilizing an earlier, faster, better planned and coordinated response, it will reduce the costs to countries and their people for response and recovery.
  • It will promote greater global and national investments in preparing for future outbreaks and strengthening national health systems. 
  • It will combine public and private resources to advance global health security, and create a new insurance market for managing pandemic risk.
The World Bank Group estimates that if the PEF had existed in mid-2014 as the Ebola outbreak was spreading rapidly in West Africa, it could have mobilized an initial $100 million as early as July to severely limit the spread and severity of the epidemic. Instead, money at that scale did not begin to flow until three months later. During that three month period, the number of Ebola cases increased tenfold. 
The Ebola epidemic has claimed more than 11,300 lives and cost at least $10 billion to date. International assistance has totaled more than $7 billion for Ebola response and recovery. 

1 comment:

  1. "Thanks For sharing this valuable information with us. i hope you will publish your knowledge about this topic so we can learn and understand.if i talking about me,We would like to introduce our-self as a leading Manufacturers and Exporters of Biopharma Machinerys Like( Fermenter, Bioreactor, Autoclave, Rotary Flask Shaker, Incubator Shaker, Biofertilizer Plant, Turn Key Based Projects, SS Vessels and Tanks, Electric Steam Boiler Etc..........)

    We are a well-known brand in India and International for manufacturing Processing Equipment and Machinery with number of reputed clients around the globe. Our Company has a distinguished record of success for providing leading technology and cost effective solutions to their clients.

    We have an established quality system for manufacturing various equipment likewise:

    Fermenter &
    Bioreactor
    &
    Autoclave
    &
    Rotary Flask Shaker
    &
    Incubator Shaker
    &
    Biofertilizer Plant
    &
    SS Vessels and Tanks
    &
    Electric Steam Boiler
    &
    Fermenter Accessory
    &
    Tc Fittings and Pipe Fittings For Pharmaceutical Machinerys
    &
    Electric Steam Boiler
    &

    --
    Regards
    UMA PHARMATECH MACHINERY(CEO)
    &
    Mr. Ankur Patel
    (+91-9726923885)
    umapharmatechmachinerys@gmail.com
    &
    Ankur patel | Managing Director | Uma Pharmatech Machinery |
    Address: 14, Narayan Chamber, Jogeshwari Estate, Sureliya Road, Pin-380026 , ahmedabad | Gujarat | India |

    Products & Services: Bioreactor
    & fermenter & Processing and Storage ss Vessel and Tank & Tc Fittings For Dairy Pharma & PP and PTFE Cartridge and Filter Housing & Pharma components & parts & Turnkey projects & Ribbon Blender & Double Cone Blender & V Blender I Paste Kettle"








































    ReplyDelete